Plain-English translation of NCT07608822 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following patients who have received a special type of dual-chamber pacemaker that uses a newer pacing technique called conduction system pacing (CSP) combined with a feature called Closed Loop Stimulation (CLS). These pacemakers are designed to work with the heart's natural electrical pathways rather than bypassing them, which may help reduce dangerous irregular heartbeats and improve how well your heart functions.
Traditional pacemakers can sometimes increase the risk of developing atrial fibrillation (a serious irregular heartbeat) when they pace the heart too frequently. This study is looking at whether newer pacemaker technology that mimics the heart's natural conduction system can reduce these dangerous rhythms while still providing the support patients with heart rhythm problems need.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of an ongoing registry that collects real-world information about how your pacemaker is working during your regular clinical care. Your doctors will monitor your pacemaker through routine office visits and device checks, and the study will track how well the advanced pacing technique is working for you and whether it helps reduce irregular heartbeats. There are no additional procedures or medications required beyond your standard pacemaker care.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Czechia
Hungary
Italy